BioMed Research International / 2014 / Article / Fig 4

Research Article

Recombinant Lysostaphin Protects Mice from Methicillin-Resistant Staphylococcus aureus Pneumonia

Figure 4

MRSA-infected animals treated with PBS, VAN, high-concentration rLys, or low-concentration rLys. (a) Weight loss in MRSA-infected animals. Mice were weighed 96 h after infection. The mouse bodyweight loss is represented as mean (±SD) of original bodyweight lost ( , Student’s -test). (b) Intrarectal temperature was monitored at different time points and the change in temperature between 0 and 96 h (or death) is plotted. (c) Increase in lung weight, represented by the mean (±SD) of original lung weight increase ( , Student’s -test). (d) Viable bacterial counts (log10 CFU/lung) in the lung homogenates of MRSA-infected mice killed at different time intervals after treatment. Values are expressed as means (±SD) of the original data, . Statistical significance was determined by one-way analysis of variance with the Bonferroni test ( , ).
602185.fig.004a
(a)
602185.fig.004b
(b)
602185.fig.004c
(c)
602185.fig.004d
(d)

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.